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Physical Activity Is Associated With Glucose
Tolerance Independent of Microvascular Function:
The Maastricht Study
David Montero, Alfons J. H. M. Houben, Annemarie Koster, Dennis M. J. Muris,
Miranda T. Schram, Ed H. Gronenschild, Simone J. S. Sep, Ronald M. A. Henry,
Carla J. H. van der Kallen, Nicolaas C. Schaper, Pieter C. Dagnelie,
Tineke A. C. M. van Geel, Stef P. J. Kremers, Hans H. C. M. Savelberg,
and Coen D. A. Stehouwer*
Context and Objective: Moderate-to-vigorous physical activity (MVPA) and physical fitness (PF) are
positively associated with glucose tolerance. Such associations may be partly conditioned by mi-
crovascular function, which is a common correlate to MVPA, PF, and glucose tolerance. To test this
hypothesis, the present study sought to investigate independent associations of MVPA and PF with
glucose tolerance and to what extent these associations are mediated by microvascular function.
Design, Setting, Participants, and Outcome Measures: Data from The Maastricht Study were used
(n  512 for MVPA and n  488 for PF analyses; mean age, 59 [SD  9] y, 52 % men). Glucose
tolerance was assessed by 2-hour postload plasma glucose levels (2hPG). The total number of
weekly hours of MVPA was estimated with the Community Healthy Activities Model Program for
Seniors questionnaire. Walking speed during the 6-minute walk test was used to evaluate PF.
Microvascular function was determined by postocclusive capillary recruitment and flowmotion
with capillaroscopy and laser Doppler flowmetry in skin microcirculation.
Results: In univariate analyses, MVPA, PF, and microvascular function variables were associated
with 2hPG. MVPA (n  512,   0.056, P  .019) and PF (n  488,   0.368, P  .006) remained
associated with 2hPG after adjustment for established cardio-metabolic risk factors and history of
cardiovascular disease; addition of microvascular function variables as potential mediators did not
materially change the associations of MVPA (  0.054, P  .024) and PF (  0.364, P  .006)
with 2hPG. No mediation effects of microvascular function variables were detected.
Conclusions: MVPA and PF were independently associated with 2hPG, irrespective of established
risk factors and generalized microvascular function. The possibility that specific microvascular
functions, eg, insulin-mediated vasodilation, influence the association of MVPA and PF with 2hPG
needs further investigation. (J Clin Endocrinol Metab 101: 3324–3332, 2016)
Exercise prescription is considered a central strategyaimed to improve glucose tolerance (1). The associ-
ation of moderate-to-vigorous physical activity (MVPA)
and cardiorespiratory fitness (henceforward physical fit-
ness [PF]) with glucose tolerance is well established but
remains incompletely explained (2–4). Theoretically, any
factor influencing glucose absorption, production, trans-
port, and/or utilization may contribute to glucose toler-
ance, as assessed by the standard 2-hour oral glucose tol-
erance test (OGTT) (5).
Sound evidence demonstrates that higher levels of
MVPA, and thereby PF, are associated with myocyte phe-
notypic modifications including increases in insulin sen-
sitivity, glucose transporters as well as enzymes responsi-
ble for the phosphorylation, storage, and oxidation of
glucose (6–8), all of which potentially improve glucose
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tolerance. Additionally, regular exercise may facilitate nu-
trient and hormone delivery to insulin-dependent tissues
through adaptations in microvascular function (9, 10).
These include enhanced endothelium dependent and in-
dependent dilator responses (11) as well as increased mi-
crovascular vasomotion, ie, the spontaneous changes in
arteriolar diameter that regulate blood flow distribution
(12). In support of the “vascular hypothesis,” changes in
microvascular function and glucose homeostasis with ex-
ercise training commonly run in parallel to each other (13,
14). Conversely, short-term physical inactivity leads to
microvascular dysfunction and decreased glucose toler-
ance (15). Thus, the relationship between MVPA, PF, and
glucose tolerance could be determined, at least in part, by
concurrent changes in microvascular function. However,
this has not yet been tested.
The aim of the present study was to investigate the
associations of MVPA and PF with glucose tolerance and
whether microvascular function may, to a degree, explain
these associations in a population-based setting. We hy-
pothesized that MVPA and PF are positively associated
with glucose tolerance and the strength of the associations
are partly explained by microvascular function.
Materials and Methods
Study population
In this study, we used data from The Maastricht Study, an
observational prospective population-based cohort study.
The rationale and methodology have been described previ-
ously (16). In brief, the study focuses on the etiology, patho-
physiology, complications and comorbidities of type 2 diabe-
tes mellitus (T2DM) and is characterized by an extensive
phenotyping approach. Eligible for participation were all in-
dividuals aged between 40 and 75 years and living in the
southern part of The Netherlands. Participants were recruited
through mass media campaigns and from the municipal reg-
istries and the regional Diabetes Patient Registry via mailings.
Recruitment was stratified according to known T2DM status
for reasons of efficiency. The present report includes cross-
sectional data from the first 866 participants, who completed
the baseline survey between November 2010 and March
2012. The examinations of each participant were performed
within a time window of 3 months. The study has been ap-
proved by the institutional medical ethical committee
(NL31329.068.10) and the Minister of Health, Welfare, and
Sports of The Netherlands, on the basis of the Health Coun-
cil’s opinion (permit 131088-105234-PG). All participants
gave written informed consent. For the present analyses, par-
ticipants were selected in whom data were available on 2-hour
postload plasma glucose levels (2hPG), microvascular func-
tion, covariates (see below), and MVPA (n  512) or PF (n 
488) (Figure 1).
Glucose tolerance
The study participants, except those who used insulin (n 
56), underwent a standardized 2-h 75-g OGTT according to
WHO guidelines (5). For safety reasons, the OGTT was not
conducted in individuals with a fasting glucose level above 11.0
mmol/L, as determined by a finger prick. Although glucose tol-
erance can be defined by fasting glucose levels, these are primar-
ily affected by -cell function (17), which is not considered a key
physiological parameter to the purpose of this study. The 2hPG
was used as the outcome measure and was assessed with a stan-
dard enzymatic hexokinase reference method.
Moderate-to-vigorous PA
MVPA was determined through 28 items from the modified
Community Healthy Activities Model Program for Seniors ques-
tionnaire (18), which evaluates the frequency of an activity
(times per week) and its duration (hours per week). Activities that
were recorded included: walking leisurely/fast/briskly, cycling
leisurely/fast/briskly, light/heavy gardening, light/heavy house-
keeping, jogging/running, swimming, tennis/badminton/table
tennis, team sport indoors/outdoors, light exercise to maintain a
physical condition (eg, stretching/flexibility), and heavy aerobic/
strength exercise. Metabolic equivalents were estimated for each
activity on the basis of the PA compendium by Ainsworth et al
(19). Only activities with at least 3 metabolic equivalents were
considered as requiring moderate or vigorous intensity for all
participants; fast walking, fast cycling, heavy gardening, heavy
household work, jogging/running, swimming, tennis, team
sport, and heavy aerobic/strength exercise (20). The total num-
ber of weekly MVPA hours was used as a study variable.
Physical fitness
The walking speed during the fast 6-minute walk test was
taken as a proxy for PF. Participants were excluded if any of these
conditions were reported: ambulatory aid, myocardial infarc-
tion, angioplasty, heart surgery, angina pectoris/chest pain,
shortness of breath, or fainting. The included participants were
instructed to walk from one end to the other of a 20-m hallway
as fast as possible while attempting to cover as much ground as
possible in the allotted 6 minutes. Technicians encouraged the
participants with the standardized statements “you’re doing
well” or “keep up the good work” but were asked not to use
other phrases. Participants were allowed to stop and rest during
the test but were instructed to resume walking as soon as they felt
able to do so.
Department of Internal Medicine (D.M., A.J.H.M.H., D.M.J.M., M.T.S., S.J.S.S., R.M.A.H., C.J.H.v.d.K., N.C.S., C.D.A.S.), Maastricht University Medical Centre and Cardiovascular Research
Institute Maastricht, Maastricht, The Netherlands; Department of Clinical Cardiology (D.M.), University Hospital Zurich, 8006 Zurich, Switzerland; Department of Social Medicine (A.K.),
Maastricht University, Maastricht, The Netherlands; CAPHRI School for Public Health and Primary Care (A.K., N.C.S., P.C.D., T.A.C.M.v.G.), Maastricht University, Maastricht, The
Netherlands; Department of Psychiatry and Neuropsychology and School for Mental Health and Neuroscience (E.H.G.), Maastricht University Medical Centre, Maastricht, The Netherlands;
Department of Epidemiology (P.C.D.), Maastricht University, Maastricht, The Netherlands; Department of Health Promotion (S.P.J.K.), NUTRIM, School for Nutrition and Translational
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Microvascular function
All vascular measurements were performed by trained tech-
nicians unaware of the participant clinical status, in quiet, tem-
perature-controlled room (24°C) after 10 minutes of acclimati-
zation with the participants in supine position, as previously
described (21, 22). Participants were allowed to have a light meal
(breakfast and/or lunch) and were asked to refrain from smoking
and caffeine intake 3 hours before the beginning of the
measurements.
Postocclusive capillary recruitment (POCR) during reactive
hyperemia was determined in the dorsal skin of the distal pha-
langes of the third and fourth finger of the right hand, using a
digital video microscope (Capiscope; KK Technology) (21). Re-
active hyperemia was induced by inflating a miniature cuff en-
circling the base of the finger inflated to suprasystolic pressure
(260 mm Hg) for 4 minutes. Capillaries were visualized 4.5 mm
proximal to the terminal row of capillaries in the middle of the
nailfold, where capillaries run perpendicularly to the skin, with
a region of interest of 1 mm2. Capillary density was defined as the
number of erythrocyte-perfused capillaries per mm2 of skin
counted during 15 seconds. The number of continuously per-
fused capillaries was counted using a semiautomatic procedure
(CapiAna) and running movie files (21). POCR was calculated
by subtracting the baseline capillary density from the peak cap-
illary density during reactive hyperemia. In addition, the maxi-
mal number of capillaries during venous occlusion (digital cuff
inflated to 60 mm Hg for 120 s) was determined (23). The intra-
and interobserver coefficient of variations of CapiAna were
2.5% and 5.6%, respectively.
Skin flowmotion (SFM) was assessed by means of a laser
Doppler system (Periflux 5000; Perimed) equipped with a ther-
mostatic laser Doppler probe (PF 457; Perimed) at the dorsal side
of the left wrist. Skin temperature was monitored continuously
and maintained at a minimum of 30°C. The laser Doppler flow-
metry (LDF) output was recorded for 25 minutes at a sample rate
of 32 Hz. Fast Fourier transform algorithm was performed using
Perisoft dedicated software (PSW version 2.50) to measure the
power density of the LDF oscillation. The frequency spectrum
between 0.01 and 1.6 Hz was divided into 5 SFM components:
1) endothelial, 0.01–0.02 Hz; 2) neurogenic, 0.02–0.06 Hz; 3)
myogenic, 0.06–0.15 Hz; 4) respiratory, 0.15–0.40 Hz; and 5)
heartbeat, 0.40–1.60 Hz (24). Each LDF frequency component
was first quantified in raw power spectral density (PSD) units.
PSD data are influenced by the variation in the LDF signal
strength between experiments (24). Therefore, the PSD value of
each frequency component was normalized, defined as the per-
centage ratio between the PSD value of that frequency subinter-
val and the PSD value of the total spectrum from 0.01 to 1.60 Hz
(obtained by the sum of the PSD value of each frequency subin-
terval) (25). Finally, a composite microvascular SFM was cal-
culated as the sum of endothelial, neurogenic, and myogenic
normalized (%) components.
Covariates
Covariates included age, sex, waist circumference, systolic
blood pressure (SBP) (Omron 705IT), smoking, total to high-
density lipoprotein (HDL) cholesterol ratio (Beckman Synchron
LX20; Beckman Coulter, Inc), triglycerides (Beckman Synchron
LX20; Beckman Coulter, Inc), baseline capillary density (Capi-
Ana), hypertension (as defined by average SBP  140 mm Hg,
diastolic BP  90 mm Hg, and/or use of antihypertensive med-
ication), medication for hypertension, medication for hyperlip-
idemia, and history of cardiovascular disease (CVD) according
to a modified version of the Rose questionnaire (16, 26).
Statistical analysis
All statistical analyses were performed using IBM SPSS ver-
sion 20 software package. Because of nonnormal distribution, all
variables were logarithmically transformed to approximate nor-
Figure 1. Flow diagram.
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mality before parametric testing. Differences in clinical status
between excluded and included individuals were assessed in or-
der to explore the presence of selection bias. Likewise, differ-
ences in clinical status, microvascular function, MVPA and PF
among tertiles of 2hPG were tested with ANOVA or the 2 test
as appropriate. Univariate associations of 2hPG with and among
covariates, microvascular function, MVPA and PF were deter-
mined by means of Pearson’s correlation coefficients (r). Multi-
ple linear regression models were used to examine the indepen-
dent association of MVPA and PF with 2hPG (Model 1).
Microvascular function variables such as POCR and composite
SFM were added as potential mediators to the regression models
2 and 3, respectively, using methods developed by Preacher and
Hayes (27). Mediation occurs when a determinant affects a de-
pendent variable indirectly through at least one interceding vari-
able, or mediator. In model 4, both POCR and composite SFM
were added as potential mediators in a simultaneous manner. All
models were adjusted for the following covariates: age, sex, waist
circumference, SBP, pack years of smoking, total to HDL cho-
lesterol ratio, triglycerides, baseline capillary density, presence of
hypertension, medication for hypertension, medication for hy-
perlipidemia, and history of CVD. Covariates may correlate to
the variables under investigation and thereby affect (confound)
their associations. The Sobel test was conducted to determine the
significance of any potential mediation effect. In addition, we
used interaction terms to explore whether any association dif-
fered according to sex, presence of hypertension or previous
CVD. A 2-tailed P  .05 (0.10 for interactions) was considered
significant.
Results
Clinical variables, microvascular function, MVPA,
and PF
Table 1 presents the characteristics of the study popu-
lation across tertiles of 2hPG in the participants included
in the MVPA analysis (n  512). Equivalent data were
observed in the PF analysis (data not shown). The study
population was comprised of 245 (52.1%) males, 110
individuals (21.5%) with T2DM, and 266 individuals
(52.0%) with hypertension. All clinical variables evalu-
ated, except for baseline capillary density, were different
across tertiles of 2hPG (P  .05). As regards microvascular
function, all variables, except for respiratory SFM, were
different across tertiles of 2hPG (P  .05). With respect to
MVPA and PF, both were different across tertiles of 2hPG
(P  .05).
Univariate analyses
The univariate linear correlation of covariates, micro-
vascular function, and MVPA/PF with 2hPG is illustrated
in Tables 2 and 3. All potential confounders (except for
total to HDL cholesterol ratio and baseline capillary den-
sity) were positively correlated to 2hPG, whereas micro-
vascular function variables and MVPA were negatively
correlated to 2hPG (Table 2). With respect to the PF anal-
ysis (Table 3), all covariates (except for baseline capillary
density) were positively correlated to 2hPG, whereas mi-
crovascular function variables and PF were negatively cor-
related to 2hPG.
As for univariate linear correlations of MVPA/PF with
microvascular function measures, MVPA was not corre-
lated to microvascular function (P  .1), except if consid-
ering females alone (n  245), in whom MVPA was pos-
itively correlated to endothelial SFM (r  0.17, P  .007),
neurogenic SFM (r  0.15, P  .021), and composite
microvascular SFM (r  0.16, P  .014). In turn, PF was
positively correlated to endothelial SFM (r  0.12, P 
.010), neurogenic SFM (r  0.15, P  .001), myogenic
SFM (r  0.18, P  .001), and composite microvascular
SFM (r  0.18, P  .001) in the study population but was
not correlated to POCR unless considering males alone
(n  255) (r  0.15, P  .014).
Independent associations
Tables 4 (MVPA analysis) and 5 (PF analysis) show
multiple regression models regarding the independent as-
sociation of MVPA/PF with 2hPG. All regression models
were adjusted for age, sex, waist circumference, SBP, pack
years of smoking, total to HDL cholesterol ratio, triglyc-
erides, baseline capillary density, presence of hyperten-
sion, medication for hypertension, medication for hyper-
lipidemia, and history of CVD. MVPA was associated
with 2hPG (  0.056, P  .019) (Table 4, model 1). The
addition of microvascular function variables as potential
mediators did not materially change this association ( 
0.054, P  .024) (Table 4, model 4). Likewise, PF was
associated with 2hPG (  0.368, P  .006) (Table 5,
model 1). The addition of microvascular function vari-
ables as potential mediators did not materially change this
association (  0.364, P  .006) (Table 5, model 4).
There were no mediation effects of microvascular function
variables in any model (P for mediation .387).
Additional analyses
Clinical variables such as age, waist circumference,
body mass index, SBP, fasting glucose, pack/years of
smoking, presence of hypertension, medication for hyper-
tension and history of CVD presented higher values,
whereas HDL cholesterol and low-density lipoprotein
cholesterol were lower, in the excluded (n  354 and n 
378 in the MVPA and PF analyses, respectively) compared
with the included participants (P  .05).
There was no interaction for the association of MVPA
and PF with 2hPG according to sex, presence of hyper-
tension or previous CVD, in unadjusted analyses and after
adjustment for potential covariates and microvascular
function variables. In addition, analyses with baseline cap-









aastricht user on 11 July 2021
illary density, % (instead of ) PORH, or maximal capil-
lary density during venous occlusion (% or ) as potential
mediators gave similar results.
Discussion
In this population-based study including middle-aged and
older individuals, we investigated the associations of
MVPA and PF with glucose tolerance and the potential
mediating role of microvascular function in these associ-
ations. The key findings were: 1) MVPA and PF, as de-
termined by walking speed from a 6-minute walk test,
were positively associated with glucose tolerance after ad-
justment for established cardio-metabolic risk factors, hy-
pertension and history of CVD; and 2) microvascular
function did not mediate these associations.
Large population studies have consistently observed a
positive relationship between PA and glucose tolerance
(2–4, 28). The causal nature of that association is denoted
by intervention studies in which exercise is the manipu-
lated variable with parameters of glycemic control as out-
come variables (29). Whether the effect of regular exercise
on glucose tolerance is explained, in part, by concomitant
changes in microvascular function has been proposed on
the basis of parallel fluctuations of microvascular dilator
reactivity and estimates of glucose homeostasis after ex-
ercise training/physical inactivity (13–15), concurring
with the concept of “vascular conditioning” (10). In this
Table 1. Clinical Variables, Microvascular Function, MVPA, and PF Across Tertiles of 2hPGa
Study Population (n  512)
T1 (2.5–5.4
mmol/L) (n  171)
T2 (5.5–7.6
mmol/L) (n  171)
T3 (7.7–25.2
mmol/L) (n  170) P
Clinical variables
Age (y) 55.5  8.2 58.4  8.2 62.4  7.6 .001
Sex (male) 78 (45.6) 83 (48.5) 106 (62.6) .004
BMI (kg/m2) 25.6  4.1 26.6  3.9 28.9  4.7 .001
Waist circumference (cm) 91.2  12.5 94.8  11.6 102.1  12.8 .001
Male (cm) 97.6  10.2 99.6  9.5 104.4  11.1 .001
Female (cm) 85.9  11.8 90.1  11.5 98.2  14.5 .001
Heart rate (bpm) 65.4  9.3 66.7  10.1 71.5  12.5 .001
SBP (mm Hg) 128.7  16.7 136.3  18.2 143.7  18.4 .001
DBP (mm Hg) 74.3  10.0 77.2  10.4 79.5  9.8 .001
Baseline capillary density (cap/mm2) 74.2  17.8 73.6  17.0 73.5  18.1 .815
Fasting glucose (mmol/L) 5.2  0.6 5.5  1.1 6.7  1.1 .001
Total cholesterol (mmol/L) 5.5  1.0 5.6  1.1 5.1  1.3 .001
HDL cholesterol (mmol/L) 1.5  0.4 1.4  0.4 1.2  0.4 .001
LDL cholesterol (mmol/L) 3.5  0.8 3.6  1.0 3.0  1.1 .001
Total to HDL cholesterol ratio 4.0  1.1 4.3  1.4 4.4  1.3 .015
Triglycerides (mmol/L) 1.1  0.6 1.3  0.8 2.0  1.4 .001
T2DM 2 (1.2) 3 (1.8) 105 (61.4) .001
Hypertension 58 (33.9) 77 (45.0) 131 (76.6) .001
History of CVD 17 (9.9) 17 (9.9) 36 (21.1) .002
DM medication 0 (0) 3 (1.8) 72 (42.1) .001
Hypertension medication 37 (21.6) 36 (21.1) 99 (57.9) .001
Smoking (pack/years) 11.2  14.3 11.1  16.8 17.2  25.1 .004
Microvascular function
POCR (cap/mm2) 30.4  15.0 33.1  15.2 28.1  15.4 .011
Endothelial SFM (%) 6.9  3.2 6.7  3.0 6.1  2.8 .035
Neurogenic SFM (%) 10.8  4.2 10.2  3.8 9.6  3.6 .014
Myogenic SFM (%) 10.8  3.6 10.6  4.0 9.6  3.6 .005
Composite microvascular SFM (%)b 28.6  8.9 27.5  8.4 25.2  8.2 .001
Respiratory SFM (%) 15.0  4.9 16.1  5.8 15.9  4.7 .140
Cardiac SFM (%) 56.4  9.1 56.4  9.2 58.9  8.9 .018
PA/PF
MVPA (h/wk) 6.4  4.6 5.8  4.2 4.9  4.1 .006
Walking speed (km/h) 5.3  2.2 5.1  2.1 4.4  2.3 .001
Data are presented as mean  SD or n (%) of the total group according to tertiles (T1–T3) of 2hPG. BMI, body mass index; DBP, diastolic BP; LDL,
low-density lipoprotein; WHR, waist to hip ratio.
a Individuals presenting with 2hPG, microvascular function, covariates (detailed in Materials and Methods), and MVPA data. Similar results were
obtained in individuals presenting with 2hPG, microvascular function, covariates, and walking speed data.
b Composite microvascular SFM was calculated as the sum of endothelial, neurogenic, and myogenic normalized (%) components.
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regard, there are a plethora of local and systemic effects of
physical (in)activity including changes in vascular shear
stress, cyclic strain, and circulating factors, potentially
contributing to adaptations in microvascular dilator/con-
strictor functions and thereby tissue blood flow regulation
(30–32). However, after adjusting for a comprehensive set
of confounding variables, the present study indicates that
microvascular function, as determined by POCR and
SFM, did not influence the association between MVPA
and 2hPG. Although speculative, microvascular function
may therefore not be the limiting factor for the improve-
ment in glucose tolerance with MVPA. Moreover, such
improvement does not seem to be attributed to any
change in endogenous glucose production (33, 34).
Other pathways through which MVPA may affect glu-
cose tolerance might involve myocyte adaptations (see
reviews in Ref. 35). These include, but are not limited to,
increased expression and/or activity of key proteins in-
volved in the regulation of insulin signal transduction,
glucose uptake and metabolism in skeletal muscle such
as Akt, glucose transporter 4 and AMP-activated pro-
tein kinase (36); indeed, they constitute potential ther-
apeutic targets mimicking the beneficial effect of exer-
cise on glucose tolerance (37).
According to our initial premise, PF was independently
associated with 2hPG. Likewise, previous reports have
found an independent predictive value of PF, as deter-
mined by peak oxygen uptake, for glucose tolerance and
related markers (3, 38, 39), although this is not a universal
finding (40). Importantly, glucose tolerance is inversely
associated with sedentary time (41), which in turn may be,
to a certain degree, dissociated from PF. On the other
hand, glucose tolerance (42) as well as PF (43) are func-
tions of the intensity of exercise training/PA. In this line,
we found a closer association of PF, as compared with
MVPA, with 2hPG. Contrary to our hypothesis, however,
microvascular functiondidnot intercede in theassociation
between PF and 2hPG. This contradicts the prevailing no-
tion supporting the enhanced microvascular function ob-
served in individuals with higher PF levels as a central link
between PF and glucose tolerance (9, 44). Collectively, our
study suggests that the impact of MVPA and PF on glucose
tolerance is not determined by microcirculatory mecha-
nisms regulating nutrient and hormone delivery, despite
the established beneficial effect of any improvement in
microvascular function on cardiovascular health (45).
Of note, microvascular function was evaluated here with
vasodilator stimuli thought to be, at least in part, endothe-
lium dependent (POCR) (46, 47) as well as by periodical
bloodflowoscillations (SFM)ofmicrovascularorigin.These
comprise common mechanisms of vasodilation and blood
flow distribution in the microcirculation, modifiable with
regular exercise (12, 24, 32, 46, 48, 49). Nevertheless, in the
presentstudy, the linearcorrelationsofMVPAandPF,onthe
one hand, and POCR and SFM, on the other hand, were not
utterly consistent and seemed to partially depend on sex.
Thus, we cannot discard that a more specific measure of
microvascular function (eg, insulin-mediated vasodilation/
capillary recruitment) might have a stronger influence on the
association of MVPA and PF with glucose tolerance. Nev-
ertheless, insulin-mediatedvasodilation,POCR,andglucose
tolerance are blunted, whereas other endothelium-depen-
Table 3. Correlations of Covariates, Microvascular






Age (y) 0.31 .001
Sex (male) 0.14 .03
Waist circumference (cm) 0.32 .001
SBP (mm Hg) 0.30 .001
Smoking (pack/years) 0.13 .004
Total to HDL cholesterol ratio 0.09 .037
Triglycerides (mmol/L) 0.34 .001
Baseline capillary density (cap/mm2) 0.03 .485
Microvascular function
POCR (cap/mm2) 0.17 .001
Endothelial SFM (%) 0.14 .003
Neurogenic SFM (%) 0.12 .008
Myogenic SFM (%) 0.13 .005
Composite microvascular SFM (%) 0.15 .001
PF
Walking speed (km/h) 0.31 .001
Table 2. Correlations of Covariates, Microvascular






Age (y) 0.29 .001
Sex (male) 0.16 .001
Waist circumference (cm) 0.33 .001
SBP (mm Hg) 0.29 .001
Smoking (pack/years) 0.12 .007
Total to HDL cholesterol ratio 0.09 .052
Triglycerides (mmol/L) 0.32 .001
Baseline capillary density (cap/mm2) 0.03 .522
Microvascular function
POCR (cap/mm2) 0.15 .001
Endothelial SFM (%) 0.14 .001
Neurogenic SFM (%) 0.12 .005
Myogenic SFM (%) 0.15 .001
Composite microvascular SFM (%) 0.17 .001
PA
MVPA (h/wk) 0.17 .001
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dentdilatorresponsesarepreservedafter short-termphysical
inactivity (15,50).This suggests thatonlycertainendothelial
dilator pathways, at least some involved in the POCR re-
sponse, are essential for our inquiry. Moreover, glucose and
insulin delivery to the myocyte may be determined by the
rhythmic change in tone of smooth muscle cells of terminal
arterioles (25, 51). In this line, exercise training enhances
microvascular SFM at rest and after acute exercise (12). Re-
gardless, given the multifactorial and unknown vascular ad-
aptations induced by regular exercise (30–32, 52), any
choiceofmeasuresofmicrovascular functioncouldhave lim-
ited the scope of the present study. The possibility remains
that the crucial microvascular parameter determining glu-
cose tolerance involves a measure of constrictor function. In
fact, glucose delivery to insulin-dependent tissues also de-
pends on the (insulin-mediated) constriction of nonnutritive
vascular routes, regulating the matching of blood flow to
metabolism (10). In addition, it has been recently inferred
that the improvement in glucose tolerance after exercise
training ispartlydependenton the increase in skeletalmuscle
capillarization (53). Further studies are warranted to deter-
mine the extent to which myocyte capillarization and micro-
vascular constrictor function, which are increased by exer-
cise training (53, 54), contribute to the exercise-induced
improvement in glucose tolerance.
Additional limitations to this study primarily reside in
the assessment of microvascular function in the skin and
not in skeletal muscle, which would be the appropriate
study tissue as regards glucose tolerance. Nonetheless,
there is compelling evidence that skin microvascular re-
sponses mirror the functional state of the microcirculation
in other tissues including skeletal muscle (55, 56). Fur-
thermore, complete data were available in a subsample of
the population that presented a healthier clinical profile
compared with excluded individuals (due to missing data),
which reduces the generalizability of the results. Ulti-
mately, conclusions about causality cannot be drawn from
Table 5. Multiple Linear Regression Models Including POCR and Composite Microvascular SFM as Potential
Mediators of the Association Between PF, as determined by Walking Speed, and 2hPG




Walking speed (km/h) 0.368 (0.628, 0.107) .006 — 0.332
2
Walking speed (km/h) 0.368 (0.628, 0.107) .006 — 0.337
POCR (cap/mm2) 0.061 (0.125, 0.002) .058 .387
3
Walking speed (km/h) 0.368 (0.628, 0.107) .006 — 0.333
Composite microvascular SFM (%) 0.044 (0.160, 0.072) .459 .618
4
Walking speed (km/h) 0.364 (0.625, 0.104) .006 — 0.337
POCR (cap/mm2) 0.060 (0.123, 0.004) .066 .396
Composite microvascular SFM (%) 0.035 (0.151, 0.081) .558 .681
All regression models were adjusted for age, sex, waist circumference, SBP, smoking, total to HDL cholesterol ratio, triglycerides, baseline capillary
density, medication, presence of hypertension, and history of CVD. , regression coefficient with 2hPG as outcome; CI, confidence interval.
Table 4. Multiple Linear Regression Models Including POCR and Composite Microvascular SFM as Potential
Mediators of the Association Between MVPA and 2hPG




MVPA (h/wk) 0.056 (0.104, 0.009) .019 — 0.355
2
MVPA (h/wk) 0.055 (0.102, 0.008) .023 — 0.359
POCR (cap/mm2) 0.047 (0.105, 0.011) .114 .445
3
MVPA (h/wk) 0.056 (0.103, 0.009) .020 — 0.358
Composite microvascular SFM (%) 0.083 (0.191, 0.025) .132 .809
4
MVPA (h/wk) 0.054 (0.101, 0.007) .024 — 0.361
POCR (cap/mm2) 0.042 (0.100, 0.017) .161 .471
Composite microvascular SFM (%) 0.073 (0.182, 0.036) .188 .817
All regression models were adjusted for age, sex, waist circumference, SBP, smoking, total to HDL cholesterol ratio, triglycerides, baseline capillary
density, medication, presence of hypertension, and history of CVD. , regression coefficient with 2hPG as outcome; CI, confidence interval.
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cross-sectional analyses; longitudinal studies are therefore
needed to confirm the findings.
In summary, this is the first cohort study demonstrating
that MVPA and PF are inversely associated with 2hPG
independent of general microvascular function and car-
dio-metabolic risk factors in middle-aged and older indi-
viduals. These findings suggest that higher levels of MVPA
and PF are associated with improved glucose tolerance
through physiological mechanisms other than enhanced
substrate and hormone delivery. From a clinical perspec-
tive, microvascular function may not limit the beneficial
effect of exercise on glucose tolerance. Further studies are
needed to determine whether specific insulin-mediated mi-
crovascular function and/or the interplay between dilator-
constrictor function may influence the association of
MVPA and PF with glucose tolerance.
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